How Good Is Kesimpta Actually?

In this video I share brand new MS drug results, comparing a new B-cell killer Kesimpta (ofatumamab) to Aubagio (teriflunomide). If you'd like to learn the results and better understand Multiple Sclerosis research, then start watching this video right now! 8/20/2020 update: Ufatumumab is now FDA approved for RMS under the trade name Kesimpta! The Boster Center for Multiple Sclerosis accepts all major insurance carriers and accepts consults from around the globe, both in office and via telemedicine. www.BosterMS.com or call 614-304-3444 to schedule! ********************************************************** COMMENT with your thoughts and questions below! I look forward to reading and responding! ********************************************************** SHARE this video: https://youtu.be/eFVkRIMuhDM *********************************************************** FOLLOW on Twitter: https://twitter.com/AaronBosterMD FRIEND on Facebook: https://www.facebook.com/AaronBosterMD/ SUBSCRIBE on YouTube: https://www.youtube.com/c/AaronBosterMD VISIT US on the web: https://bosterms.com/ VISIT us on web: BosterMS.com *********************************************************** NOTE: Make sure to talk to your provider before ANY treatment decision. We hope to educate, empower and energize those impacted by Multiple Sclerosis. This channel consists of a collection of formal lectures and informal video clips about MS to help education others. These videos do not provide medical advice and are for informational/educational purposes only. The videos are not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen in any of our videos. They are just to help educate you about the condition guys!